You are here

Article metrics

Article menu
Immunotherapy biomarkers
Original research
ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer

 

Online download statistics by month:

Online download statistics by month: February 2023 to January 2026

AbstractFullPdf
Feb 202321621877
Mar 2023250256135
Apr 202312212257
May 2023999941
Jun 2023838630
Jul 202310110145
Aug 202315515552
Sep 202312212553
Oct 202311011359
Nov 2023939335
Dec 2023767745
Jan 202410110178
Feb 2024686860
Mar 2024888875
Apr 2024868674
May 2024707349
Jun 2024666853
Jul 2024828451
Aug 20244745112
Sep 2024697751
Oct 2024767949
Nov 2024919261
Dec 202411511759
Jan 2025787852
Feb 202511311557
Mar 2025757566
Apr 2025919145
May 2025717154
Jun 2025666840
Jul 2025110
Aug 2025110
Dec 2025550
Jan 2026001
Total288729281716